Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Countries and organisations
Explore psilocybin trials by country, sponsor and research facility. Compare registry status, study-start trends, conditions and mapped research sites.
Free access · No subscription for research tools or data exports
Explore registry geography and organisations
5 trials match this view; 6 mapped facilities. Latest indexed registry check Oct 9, 2026 01:24 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.
Enrollment sum: 198 across 5 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.
Recorded study-start years
Current indexed registry status
Reported research conditions
Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.
Matching trial records
| Trial | Sponsor and phase | Status | Enrollment | Start / primary completion / completion | Research workflow |
|---|---|---|---|---|---|
| Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled TrialAdvanced Cancer · Stage IV Solid Tumor Cancer · Stage IV Sarcoma of Bone · Stage IV Lymphoma · Stage IV Melanoma · Endocrine Cancer | University Health Network, Toronto PHASE2 | Not yet recruiting Registry updated 2026-09-15 | 46 ESTIMATED | 2026-09-14 2028-12-30 2029-07-30 | |
| Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot StudyBipolar Depression | University Health Network, Toronto PHASE1 | Active, not recruiting Registry updated 2026-08-10 | 30 ESTIMATED | 2024-10-09 2026-09-01 2027-01-01 | |
| Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)Major Depressive Disorder · Depression · Treatment-Resistant Depression · Mood Disorders | University Health Network, Toronto PHASE2 | Active, not recruiting Registry updated 2026-07-09 | 92 ESTIMATED | 2024-02-05 2026-07-28 2026-12-28 | |
| Psilocybin-assisted Existential, Attachment and Relational (PEARL) Therapy for Caregivers of Patients With Advanced Cancer: A Phase II Open-Label TrialCaregiver Distress | University Health Network, Toronto PHASE2 | Recruiting Registry updated 2026-06-23 | 15 ESTIMATED | 2025-07-16 2027-12-02 2027-12-02 | |
| Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Phase II Open-Label TrialAdvanced Cancer · Stage IV Solid Tumor Cancer · Stage IV Sarcoma of Bone · Stage IV Lymphoma · Stage IV Melanoma · Endocrine Cancer | University Health Network, Toronto PHASE2 | Active, not recruiting Registry updated 2026-06-22 | 15 ESTIMATED | 2024-06-06 2026-12-15 2026-12-15 |
Reported research facilities
University Health NetworkToronto, Ontario, Canada
Toronto Western Hospital - University Health NetworkToronto, Ontario, Canada
Toronto Western HospitalToronto, Ontario, Canada
Centre for Addiction and Mental Health (CAMH)Toronto, Ontario, Canada
Toronto General HospitalToronto, Ontario, Canada
Princess Margaret Cancer CentreToronto, Ontario, Canada
This list includes mapped sites of matching trials, including international sites; locations without usable coordinates are omitted. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.